Martek Revenues Grow On International Demand For life’sDHA
This article was originally published in The Tan Sheet
Executive Summary
Sales of life'sDHA to international infant formula manufacturers helped drive nutritional oil developer Martek Biosciences' revenue up 18 percent to a record $82.9 million during its fiscal 2008 first quarter, the firm says
You may also be interested in...
Martek, Numico deal
Nutritional oil manufacturer Martek Biosciences will exclusively supply infant formula producer Numico with ARA and microbially-derived DHA for its infant formula products under a 15-year deal between the firms, Martek announces Feb. 19. The agreement extends an existing license agreement that has been in place since 1994, but allows Numico to terminate the arrangement as early as January 2012, Martek states. "With this new agreement, more than 70 percent of Martek's business in the infant formula market is subject to multi-year sole source agreements," firm notes...
Expo West In Brief
Horizon milk with DHA: Martek Bioscience has entered into a new agreement with Dean Foods Company's WhiteWave Foods subsidiary that will add Martek's life'sDHA to the Horizon Organic milk and new Rachel's natural yogurt brand products, the algal DHA firm announces March 9. The products are expected to debut in mid-2007, Martek notes. Under the 15-year deal, Dean and WhiteWave will purchase all their DHA omega-3 needs from Martek for products in the U.S. and other designated territories. "I believe that this agreement with Dean will serve as an important step forward towards the widespread use of Martek's life'sDHA in a variety of food and beverage products," Martek CEO Steve Dubin says. A previous agreement between the firms added life'sDHA in Silk Plus Omega-3 DHA soy milk (1"The Tan Sheet" Feb. 5, 2007, In Brief). At the show, WhiteWave also introduced Silk Plus Fiber and the Rachel's line of premium natural yogurts, which will be available nationwide in select channels...
J&J Consumer Sales Slip Even As Recalled Brands, Seasonal Items Reach Stores
J&J reports worldwide consumer sales dipped 0.6% to $3.6 billion despite retailers buying more upper respiratory and analgesic products to prepare for the cough and cold season. But in key OTC categories the firm is regaining market share it lost when its iconic brands were temporarily not available.